Boogie Fland
Story Poster
42:45
Reed Report: SEC Unfiltered's Dave Schumate previews A&M at Florida
11 days ago by Luke Evangelist
Texas A&M has just three regular-season games remaining as Buzz Williams & Co. head of Gainesville for a Saturday night clash with No. 3 Florida. On this edition of the Reed Report, Dave Schumate of SEC Unfiltered joined us to breakdown the latest from around the league.
Story Poster
Keys to the Game: No. 8 Texas A&M vs. Arkansas
25 days ago by Luke Evangelist
The red-hot Arkansas Razorbacks come to Reed Arena on Saturday as the eighth-ranked Fightin' Texas Aggies look to extend their four-game winning streak. With just seven regular-season games remaining, Saturday is another key game for A&M to stay in the hunt in the SEC.
Story Poster
Scouting Report: No. 8 Texas A&M vs. Arkansas
25 days ago by Tom Schuberth
John Calipari's first season in Fayetteville got off to a slow start in SEC play, but Arkansas has won three of its last four to get back on the NCAA Tournament bubble. One of the hottest teams in the league, the Hogs venture to Reed Arena for a Saturday showdown with A&M.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
37:09
Reed Report: Preparing for March Madness with JBR Bracketology
26 days ago by Luke Evangelist
No. 8 Texas A&M is currently projected as a No. 2 seed in the upcoming NCAA Tournament, and on Saturday, the selection committee will share its in-season top 16 seeds. Ahead of that, JBR Bracketology joined this edition of the Reed Report as the postseason is inching closer.
Story Poster
SEC basketball midseason power rankings, superlatives & more
1 mo ago by Luke Evangelist
Over 20 games into a grueling season, and with only nine games left in regular-season play, Luke Evangelist runs down the biggest notes from the SEC and even offers some midseason superlatives from across college basketball's best league.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.